These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20449482)

  • 21. Microwave-assisted solution-phase parallel synthesis of 2,4,6-trisubstituted pyrimidines.
    Nie A; Wang J; Huang Z
    J Comb Chem; 2006; 8(5):646-8. PubMed ID: 16961399
    [No Abstract]   [Full Text] [Related]  

  • 22. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid-phase syntheses of 6-arylpyridazin-3(2H)-ones.
    Salives R; Dupas G; Plé N; Quéguiner G; Turck A; George P; Sevrin M; Frost J; Almario A; Li A
    J Comb Chem; 2005; 7(3):414-20. PubMed ID: 15877470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microwave-assisted parallel synthesis of a 14-helical beta-peptide library.
    Murray JK; Gellman SH
    J Comb Chem; 2006; 8(1):58-65. PubMed ID: 16398554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stepwise combinatorial evolution of Akt bisubstrate inhibitors.
    Lee JH; Kumar S; Lawrence DS
    Chembiochem; 2008 Mar; 9(4):507-9. PubMed ID: 18224646
    [No Abstract]   [Full Text] [Related]  

  • 26. Process optimization using combinatorial design principles: parallel synthesis and design of experiment methods.
    Gooding OW
    Curr Opin Chem Biol; 2004 Jun; 8(3):297-304. PubMed ID: 15183328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.
    Allocco JJ; Donald R; Zhong T; Lee A; Tang YS; Hendrickson RC; Liberator P; Nare B
    Int J Parasitol; 2006 Oct; 36(12):1249-59. PubMed ID: 16890941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.
    Cozza G; Gianoncelli A; Montopoli M; Caparrotta L; Venerando A; Meggio F; Pinna LA; Zagotto G; Moro S
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5672-5. PubMed ID: 18799313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semi-automated microwave-assisted SPPS: Optimization of protocols and synthesis of difficult sequences.
    Pedersen SL; Sørensen KK; Jensen KJ
    Biopolymers; 2010; 94(2):206-12. PubMed ID: 20225294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent kinases.
    Braña MF; Cacho M; García ML; Mayoral EP; López B; de Pascual-Teresa B; Ramos A; Acero N; Llinares F; Muñoz-Mingarro D; Lozach O; Meijer L
    J Med Chem; 2005 Nov; 48(22):6843-54. PubMed ID: 16250643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of kinase-biased compounds in the search for lead inhibitors of kinase targets.
    Lai JY; Langston S; Adams R; Beevers RE; Boyce R; Burckhardt S; Cobb J; Ferguson Y; Figueroa E; Grimster N; Henry AH; Khan N; Jenkins K; Jones MW; Judkins R; Major J; Masood A; Nally J; Payne H; Payne L; Raphy G; Raynham T; Reader J; Reader V; Reid A; Ruprah P; Shaw M; Sore H; Stirling M; Talbot A; Taylor J; Thompson S; Wada H; Walker D
    Med Res Rev; 2005 May; 25(3):310-30. PubMed ID: 15593285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening.
    Usui T; Ban HS; Kawada J; Hirokawa T; Nakamura H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):285-8. PubMed ID: 17983745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based virtual screening of Src kinase inhibitors.
    Lee K; Kim J; Jeong KW; Lee KW; Lee Y; Song JY; Kim MS; Lee GS; Kim Y
    Bioorg Med Chem; 2009 Apr; 17(8):3152-61. PubMed ID: 19321350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase.
    Sweeney ZK; Acharya S; Briggs A; Dunn JP; Elworthy TR; Fretland J; Giannetti AM; Heilek G; Li Y; Kaiser AC; Martin M; Saito YD; Smith M; Suh JM; Swallow S; Wu J; Hang JQ; Zhou AS; Klumpp K
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4348-51. PubMed ID: 18625554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design strategies for protein kinase inhibitors.
    Parang K; Sun G
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):617-29. PubMed ID: 15503864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of anticoccidial agents: 5,6-diarylimidazo[2,1-b][1,3]thiazoles.
    Scribner A; Meitz S; Fisher M; Wyvratt M; Leavitt P; Liberator P; Gurnett A; Brown C; Mathew J; Thompson D; Schmatz D; Biftu T
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5263-7. PubMed ID: 18789686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinatorial materials research applied to the development of new surface coatings VII: an automated system for adhesion testing.
    Chisholm BJ; Webster DC; Bennett JC; Berry M; Christianson D; Kim J; Mayo B; Gubbins N
    Rev Sci Instrum; 2007 Jul; 78(7):072213. PubMed ID: 17672744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An expeditious synthesis of imatinib and analogues utilising flow chemistry methods.
    Hopkin MD; Baxendale IR; Ley SV
    Org Biomol Chem; 2013 Mar; 11(11):1822-39. PubMed ID: 23247615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A minimalist approach to fragment-based ligand design using common rings and linkers: application to kinase inhibitors.
    Aronov AM; Bemis GW
    Proteins; 2004 Oct; 57(1):36-50. PubMed ID: 15326593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining enabling techniques in organic synthesis: continuous flow processes with heterogenized catalysts.
    Kirschning A; Solodenko W; Mennecke K
    Chemistry; 2006 Aug; 12(23):5972-90. PubMed ID: 16832800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.